FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065961022> ?p ?o ?g. }

• W2065961022 endingPage "1455" @default.
• W2065961022 startingPage "1445" @default.
• W2065961022 abstract "Glycogen synthase kinase-3 (GSK-3) has been proposed as the main kinase able to aberrantly phosphorylate tau in Alzheimer's disease (AD) and related tauopathies, raising the possibility of designing novel therapeutic interventions for AD based on GSK-3 inhibition. Lithium, a widely used drug for affective disorders, inhibits GSK-3 at therapeutically relevant concentrations. Therefore, it was of great interest to test the possible protective effects of lithium in an AD animal model based on GSK-3 overexpression. We had previously generated a double transgenic model, overexpressing GSK-3beta in a conditional manner, using the Tet-off system and tau protein carrying a triple FTDP-17 (frontotemporal dementia and parkinsonism linked to chromosome 17) mutation. This transgenic line shows tau hyperphosphorylation in hippocampal neurones accompanied by neurofibrillary tangles (NFTs). We used this transgenic model to address two issues: first, whether chronic lithium treatment is able to prevent the formation of aberrant tau aggregates that result from the overexpression of FTDP-17 tau and GSK-3beta; second, whether lithium is able to change back already formed NFTs in aged animals. Our data suggest that progression of the tauopathy can be prevented by administration of lithium when the first signs of neuropathology appear. Furthermore, it is still possible to partially reverse tau pathology in advanced stages of the disease, although NFT-like structures cannot be changed. The same results were obtained after shut-down of GSK-3beta overexpression, supporting the possibility that GSK-3 inhibition is not sufficient to reverse NFT-like aggregates." @default.
• W2065961022 created "2016-06-24" @default.
• W2065961022 creator A5019340831 @default.
• W2065961022 creator A5063558026 @default.
• W2065961022 creator A5082463004 @default.
• W2065961022 creator A5084018006 @default.
• W2065961022 creator A5087593615 @default.
• W2065961022 date "2006-12-01" @default.
• W2065961022 modified "2023-10-17" @default.
• W2065961022 title "Chronic lithium administration to FTDP-17 tau and GSK-3? overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert" @default.
• W2065961022 cites W126426573 @default.
• W2065961022 cites W1483825698 @default.
• W2065961022 cites W1496294957 @default.
• W2065961022 cites W1611407165 @default.
• W2065961022 cites W1937509739 @default.
• W2065961022 cites W1975425153 @default.
• W2065961022 cites W1982947429 @default.
• W2065961022 cites W1984453732 @default.
• W2065961022 cites W1985446830 @default.
• W2065961022 cites W1986537744 @default.
• W2065961022 cites W1996917933 @default.
• W2065961022 cites W2005853389 @default.
• W2065961022 cites W2027331854 @default.
• W2065961022 cites W2031102482 @default.
• W2065961022 cites W2031179697 @default.
• W2065961022 cites W2031864556 @default.
• W2065961022 cites W2038084705 @default.
• W2065961022 cites W2039550162 @default.
• W2065961022 cites W2042942040 @default.
• W2065961022 cites W2043661712 @default.
• W2065961022 cites W2051788298 @default.
• W2065961022 cites W2058570072 @default.
• W2065961022 cites W2065741837 @default.
• W2065961022 cites W2067042124 @default.
• W2065961022 cites W2069247119 @default.
• W2065961022 cites W2073264699 @default.
• W2065961022 cites W2073292164 @default.
• W2065961022 cites W2077651746 @default.
• W2065961022 cites W2078961126 @default.
• W2065961022 cites W2087745495 @default.
• W2065961022 cites W2088601627 @default.
• W2065961022 cites W2106200048 @default.
• W2065961022 cites W2114358785 @default.
• W2065961022 cites W2125904354 @default.
• W2065961022 cites W2135309154 @default.
• W2065961022 cites W2150802333 @default.
• W2065961022 cites W2154908600 @default.
• W2065961022 cites W2164136371 @default.
• W2065961022 cites W2168957011 @default.
• W2065961022 cites W2171660142 @default.
• W2065961022 cites W2283169761 @default.
• W2065961022 cites W4229561042 @default.
• W2065961022 doi "https://doi.org/10.1111/j.1471-4159.2006.04139.x" @default.
• W2065961022 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17059563" @default.
• W2065961022 hasPublicationYear "2006" @default.
• W2065961022 type Work @default.
• W2065961022 sameAs 2065961022 @default.
• W2065961022 citedByCount "193" @default.
• W2065961022 countsByYear W20659610222012 @default.
• W2065961022 countsByYear W20659610222013 @default.
• W2065961022 countsByYear W20659610222014 @default.
• W2065961022 countsByYear W20659610222015 @default.
• W2065961022 countsByYear W20659610222016 @default.
• W2065961022 countsByYear W20659610222017 @default.
• W2065961022 countsByYear W20659610222018 @default.
• W2065961022 countsByYear W20659610222019 @default.
• W2065961022 countsByYear W20659610222020 @default.
• W2065961022 countsByYear W20659610222021 @default.
• W2065961022 countsByYear W20659610222022 @default.
• W2065961022 countsByYear W20659610222023 @default.
• W2065961022 crossrefType "journal-article" @default.
• W2065961022 hasAuthorship W2065961022A5019340831 @default.
• W2065961022 hasAuthorship W2065961022A5063558026 @default.
• W2065961022 hasAuthorship W2065961022A5082463004 @default.
• W2065961022 hasAuthorship W2065961022A5084018006 @default.
• W2065961022 hasAuthorship W2065961022A5087593615 @default.
• W2065961022 hasBestOaLocation W20659610221 @default.
• W2065961022 hasConcept C11960822 @default.
• W2065961022 hasConcept C134018914 @default.
• W2065961022 hasConcept C142724271 @default.
• W2065961022 hasConcept C15744967 @default.
• W2065961022 hasConcept C169760540 @default.
• W2065961022 hasConcept C177738377 @default.
• W2065961022 hasConcept C182996813 @default.
• W2065961022 hasConcept C185592680 @default.
• W2065961022 hasConcept C192118531 @default.
• W2065961022 hasConcept C202444582 @default.
• W2065961022 hasConcept C2776925932 @default.
• W2065961022 hasConcept C2777739294 @default.
• W2065961022 hasConcept C2778198054 @default.
• W2065961022 hasConcept C2778541603 @default.
• W2065961022 hasConcept C2778670691 @default.
• W2065961022 hasConcept C2779134260 @default.
• W2065961022 hasConcept C2779483572 @default.
• W2065961022 hasConcept C2779721402 @default.
• W2065961022 hasConcept C2780130745 @default.
• W2065961022 hasConcept C33923547 @default.
• W2065961022 hasConcept C502032728 @default.

• next